Could This Device Replace Drugs for Rheumatoid Arthritis Treatment?

SetPoint Medical has launched a pilot trial to assess the safety and efficacy of a bioelectronics device in patients, who are suffering from rheumatoid arthritis and who are not adequately responsive to multiple biologic agents. The study will enroll a total of 15 subjects, aged 22 to 75, across seven U.S. investigational centers. Valencia, CA-based SetPoint's approach toward treating RA is designed to supplement the body's natural inflammatory reflex by providing "built-in" therapy and is intended to improve safety compared with drugs or biologic solutions. Currently pharmaceutical options are used to treat RA. These treatments can have serious side effects and can be very costly. “We’re trying to use bioelectric medicine, or little digital doses of electricity, which are pulses down the vagus nerve, to modulate this disease,” Anthony Arnold, CEO of SetPoint Medical, told MD+DI. The technology is implanted in the left side of the neck, just above the collarbone, through an incision about one-inch long. Arnold said it’s a pretty routine procedure that can be performed in under an hour. “The compliance [from patients] will be great,” Arnold said. "Once the device is implanted in the patient it does all of the delivery of the dosing by itself autonomously.” Join us at the BIOMEDevice Boston Expo,  April 18–19, 2018. Use promo code "MDDI" for 20% off conference registration and free expo access.   SetPoint previously published results from a proof-of-conce...
Source: MDDI - Category: Medical Devices Authors: Tags: Digital Health Implants Source Type: news